Dr. Scott Benjamin Schneider, MD

Dr. Schneider practices at Compass Oncology in Vancouver, Washington.

Dr. Schneider's NPI, 1336142926, was assigned on May 27, 2005. Dr. Schneider graduated from David Geffen School of Medicine at UCLA in 1991. Dr. Schneider's Washington license number on file is MD00033560.

Dr. Schneider's primary practice is Compass Oncology, at 210 Se 136th Ave, Vancouver, WA 98684-6930. The practice phone is (360) 944-9889.

Dr. Schneider's primary practice is Compass Oncology in Vancouver, Washington. Dr. Schneider is also affiliated with PeaceHealth Southwest Medical Center. The medical group on file is Compass Oncology. Dmand AI also links Dr. Schneider to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schneider practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Schneider's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Schneider is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Schneider's licenses on file in 5 states: Washington, California, South Dakota, Oregon and North Carolina.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain tumor radiation, breast cancer radiation, colorectal cancer radiation, lung cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions Dr. Schneider treats.

CMS data shows 4,297 Medicare services from Dr. Schneider across 22 procedure codes in 2024, for 163 Medicare patients. Medicare paid $421,318 for them. Every service was in an office.

CMS counts 163 Medicare patients who saw Dr. Schneider in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have cancer, and 70% have high blood pressure. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schneider's median patient age at 73, with 32% women.

In 2024, Dr. Schneider wrote 281 Medicare Part D claims for 98 patients. 91% of them were for generic drugs. CMS names the drug for 202 of them, across 5 drugs with 11 or more claims each, at $2,655 in total drug cost. In 2023, CMS named 121 claims across 3 drugs.

Dr. Schneider accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Schneider.

CMS Open Payments shows 16 general payments to Dr. Schneider from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 95% of the total. Abbvie Inc. paid the most, $7,745.

Dmand AI lists 9 awards for Dr. Schneider, most recently CMS Stage 1 2012 in 2012.

Dr. Schneider graduated from David Geffen School of Medicine at UCLA in 1991.

Dr. Schneider is in network with 10 carriers, including Aetna, United Healthcare and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.